Rankings
▼
Calendar
ESPR Q1 2016 Earnings — Esperion Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ESPR
Esperion Therapeutics, Inc.
$519M
Q1 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$15M
Net Income
-$15M
EPS (Diluted)
$-0.65
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$286M
Total Liabilities
$8M
Stockholders' Equity
$278M
Cash & Equivalents
$37M
← FY 2016
All Quarters
Q2 2016 →
